Balancing the interplay between ligand ejection and therapeutic window light absorption in ruthenium polypyridyl complexes

Balancing the interplay between ligand ejection and therapeutic window light absorption in ruthenium polypyridyl complexes
复制标题

DOI:
10.1039/d2dt01237e
复制
发表时间:
2022-06-15
影响因子:
4
通讯作者:
Ashford,Dennis L.
Ashford,Dennis L.
中科院分区:
化学2区
文献类型:
--
作者:
McCullough,Annie B.;Chen,Jiaqi;Ashford,Dennis L.

文献摘要

相似文献

钌多吡啶配合物作为光化学疗法(photochemotherapies,PCT)已经获得了显著的兴趣,其中它们的激发态性质在光细胞毒性机制和功效中起关键作用。本文报道了一系列用于模拟PCTs的[Ru(bpy)2(N-N)]2+(其中bpy = 2,2 ′-联吡啶; N-N是一个双齿多吡啶配体)型钌(II)多吡啶配合物的电化学、光谱化学和电子物理分析。在该系列中,通过增加共轭和/或引入电负性杂原子来修饰N-N配体,以将金属-配体电荷转移(MLCT)吸收转移到PCT的治疗窗口(600-1100 nm)附近,同时引入空间体积以触发光诱导配体解离。最低能量MLCT吸收峰从λmax = 454 nm红移到564 nm,发射能量从λmax = 620 nm降低到850 nm。光诱导配体喷射和温度依赖性发射研究揭示了红移MLCT激发和进入解离3dd* 态之间的重要相互作用,对于测量的复合物,3 MLCT * 和3dd* 态之间的能垒范围为850 cm−1至2580 cm−1。这项工作表明,在未来的配体和配合物的PCT设计的MLCT歧管和3dd* 状态能级的理解的重要性。
Ruthenium polypyridyl complexes have gained significant interest as photochemotherapies (PCTs) where their excited-state properties play a critical role in the photo-cytotoxicity mechanism and efficacy. Herein we report a systematic electrochemical, spectrochemical, and photophysical analysis of a series of ruthenium(II) polypyridyl complexes of the type [Ru(bpy)2(N–N)]2+ (where bpy = 2,2′-bipyridine; N–N is a bidentate polypyridyl ligand) designed to mimic PCTs. In this series, the N–N ligand was modified through increased conjugation and/or incorporation of electronegative heteroatoms to shift the metal-to-ligand charge-transfer (MLCT) absorptions near the therapeutic window for PCTs (600–1100 nm) while incorporating steric bulk to trigger photoinduced ligand dissociation. The lowest energy MLCT absorptions were red-shifted from λmax = 454 nm to 564 nm, with emission energies decreasing from λmax = 620 nm to 850 nm. Photoinduced ligand ejection and temperature-dependent emission studies revealed an important interplay between red-shifting MLCT absorptions and accessing the dissociative 3dd* states, with energy barriers between the 3MLCT* and 3dd* states ranging from 850 cm−1 to 2580 cm−1 for the complexes measured. This work demonstrates the importance of understanding both the MLCT manifold and 3dd* state energy levels in the future design of ligands and complexes for PCT.